At a glance

ClinicalIndex Comparison Record

Phase 3Completed

Drug / intervention

hysterectomy +1 moreprocedure

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00114088

NCT00114088Phase 3Completed

Compare CT.gov

Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB)

Agency for Healthcare Research and Quality (AHRQ)·interventional·Posted Jun 14, 2005·Updated Jun 24, 2005

In Brief

A Phase 3 clinical trial evaluating hysterectomy and endometrial ablation for Menorrhagia and Uterine Bleeding. Completed.

Detailed Summary

STOP-DUB is a multicenter randomized clinical trial that is assessing the efficacy and effectiveness of hysterectomy versus endometrial ablation (EA) for dysfunctional uterine bleeding (DUB) in women for whom medical management has not provided relief.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsMenorrhagia, Uterine Bleeding

Countries--

Collaborators--

Timeline

Phase 3CompletedFinished

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartNov 1997

Study CompletionJan 2004

First PostedJun 2005

TodayJul 2026

First PostedJun 14, 2005

Enrollment StartNov 1, 1997

Study CompletionJan 1, 2004

TodayJul 2, 2026

Posted 21.1 years ago

Interventions

hysterectomyprocedure

endometrial ablationprocedure